Announced
Xoma Royalty to acquire HilleVaxfrom.
Synopsis
Xoma Royalty, a biotechnology royalty aggregator, agreed to acquire HilleVax, a biopharmaceutical company. Financial terms were not disclosed.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Claim DealAll rights reserved. Copyright © 2025 Datasite